SBC Medical Group

What SBC Medical Group does

SBC Medical Group Holdings Incorporated (NASDAQ: SBC) is a management services organization that provides operational, clinical, and branding support to a network of 283 franchise aesthetic healthcare clinics, anchored by the Shonan Beauty Clinic brand in Japan. Founded in 2000 and taken public via SPAC merger with Pono Capital 2 in September 2024, the company reports approximately $174 million in FY2025 revenue while the underlying franchise network generated $1.163 billion in total clinic revenue, with 6.63 million annual customer visits at a 72% repeat rate. The business model combines recurring franchise fees with equity-style returns from minority investments and consulting/managed services delivered to international partners.

The company's product surface spans a multi-brand portfolio: Shonan Beauty Clinic (mass-market Japanese aesthetic dermatology), NEO Skin Clinic (premium/VIP flagship targeting international patients, with Ginza location opened March 2026), The Chelsea Clinic (acquired via Singapore-based AHH in November 2024), and the SBC Wellness 2.0 longevity platform launched March 2026. Underlying technology includes a proprietary "Talk Bridge" multilingual interpretation app, AI-driven call center infrastructure credited with 31% labor reduction and 30% faster response times, and an AI-managed health platform leveraging data across the clinic network. New CTO Sheng-FU Hsiao, appointed March 1, 2026, leads the AI and digital transformation strategy.

Internationally, SBC has executed a coordinated expansion roadmap: AHH acquisition in Singapore (21 clinics, November 2024) as the regional hub, consulting agreement with BLEZ ASIA in Thailand (November 2025, with full dermatology launch June 2026), strategic minority equity investment in OrangeTwist covering 24 U.S. MedSpa locations across six states (January 2026), and a strategic alliance with Shanghai-based Daibi Medical Aesthetics (February 2026) to drive inbound medical tourism. The company holds approximately $164 million in cash against a market capitalization of $444–450 million, carries a $50 million shelf registration, a $20 million share repurchase authorization through December 2026, and has stated a public goal of reaching 1,000 clinics over a ten-year horizon.

Name

SBC Medical Group

Legal name

SBC Medical Group Holdings Incorporated

Website

https://sbc-holdings.com

Company type

Public

Founded year

2000

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

SBC Medical Group Holdings is a Nasdaq-listed management services organization that supports a network of 283 aesthetic healthcare franchise clinics, primarily under the Shonan Beauty Clinic brand in Japan, serving 6.6 million annual patient visits and expanding into Singapore, Thailand, the U.S., and China.

Ownership category

akta.pro rank

Headquarters

HQ city

Tokyo

HQ country

Japan

HQ region

Asia

Offices4 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Franchise Fee Revenue: SBC Medical generates revenue primarily through franchise fees from its network of 283 affiliated clinic locations across Japan, providing management support, branding, protocols, and operational guidance.
2. Clinic Service Revenue: Revenue from total clinic operations including patient visits across the franchise network. Total clinic revenue reached $1,163 million in FY2025 with average revenue per customer of $316, up 11% year-over-year.
3. Consulting and Management Services: Revenue from providing consulting services to international partners including BLEZ ASIA in Thailand and other ASEAN market entries, offering clinical protocol development and Japanese-quality aesthetic medicine expertise.
4. Equity Investment Returns: Returns from minority equity investments in partners like OrangeTwist in the U.S. market as part of Phase 1 global expansion strategy.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels4 records

Core offering

SBC Medical Group operates a franchise-based aesthetic healthcare and dermatology clinic network, with 283 affiliated clinic locations across Japan handling approximately 6.6 million annual patient visits under the flagship Shonan Beauty Clinic brand. The company provides end-to-end franchise management services including clinical protocols, branding, marketing, and operational infrastructure to affiliated clinics, while expanding internationally via equity investments, partnerships, and acquisitions in the U.S., Singapore, and Thailand.

Product overview

SBC Medical Group Holdings Incorporated is a Nasdaq-listed Medical Services Organization that operates a multi-brand portfolio of aesthetic healthcare clinics and wellness platforms. The core offering centers on the Shonan Beauty Clinic brand (283 franchise locations), supported by the newer NEO Skin Clinic sub-brand targeting premium international patients. The company provides end-to-end management support including clinical protocols, technology integration, and operational infrastructure. Growth strategy includes organic expansion (SBC Wellness 2.0 longevity platform), strategic M&A (AHH acquisition in Singapore, Waqoo), and international partnerships (OrangeTwist in the U.S., BLEZ ASIA in Thailand). AI-driven transformation is underway under new CTO leadership, leveraging 6.63 million annual patient visits to build an automated management infrastructure.

Differentiator

Problem solved

Functional benefit

Brands

• NEO Skin Clinic: Flagship aesthetic dermatology clinic brand with VIP accommodations targeting international patients
• The Chelsea Clinic
• NEO Skin Clinic 銀座 (Ginza)

Products and services

• Shonan Beauty Clinic
• NEO Skin Clinic
• SBC Wellness 2.0
• OrangeTwist
• The Chelsea Clinic
• BLEZ CLINIC

Quantifiable outcome

• Revenue growth of 9.6% annually projected over next three years, reaching $222.7 million by 2029
• +4 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature3 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Daibi Medical AestheticscoreStrategic or Co-development Partner · 2 February 2026Strategic alliance between Medical Corporation Nasukai (operator of Shonan Beauty Clinic) and Shanghai-based Daibi Medical Aesthetics. Collaboration aims to share clinical expertise and operational know-how, enhance Shonan Beauty Clinic brand recognition in China, and support inbound medical tourism to Japan. Inbound visits nearly tripled from ~600 in early 2024 to ~1,700 by end of 2025.
• OrangeTwistcoreStrategic or Co-development Partner · 5 January 2026Strategic minority equity investment and partnership with U.S.-based MedSpa chain operating 24 locations across 6 states (California, Texas, Washington, Nevada, Colorado, New Jersey). Collaboration on clinical protocols, technology integration, and operational scalability. Forms Phase 1 of SBC's multi-year global expansion roadmap. OrangeTwist also acquired 6 additional locations in Colorado and Nevada in conjunction with the partnership.
• BLEZ ASIA Co., Ltd.coreStrategic or Co-development Partner · 14 November 2025Consulting agreement for management support of dermatological clinic in Bangkok's Asok district. SBC provides clinical protocol development, Japanese-quality standards, and assists in selecting medical devices. Operations expected to commence by year-end with full aesthetic dermatology launch in June 2026. Partnership represents next step in ASEAN expansion following Singapore launch, targeting Thai market projected to reach USD 1.118 billion by 2033.
• Chulabhorn International College of Medicine (CICM) at Thammasat UniversityminorStrategic or Co-development Partner · 14 November 2025Academic collaboration following November 2025 MoU signing. Thai specialists observed Shonan Beauty Clinic operations, participated in physician education sessions, and discussed treatment protocols for Asian skin types. First concrete step in promoting international academic exchange as part of global expansion strategy.
• Waqoo, Inc.coreStrategic or Co-development Partner · 14 November 2025Tender offer to acquire 575,000 shares at JPY 1,900 per share, aimed at accelerating Waqoo's research and development efforts. Tender offer process scheduled between November 14 and December 12, 2025.
• Aesthetic Healthcare Holdings Pte. Ltd. (AHH)coreStrategic or Co-development Partner · 13 November 2024Definitive agreement to acquire Singapore-based AHH operating 21 aesthetic medical clinics across four brands. All-cash transaction marked SBC's first step in acquisition-driven growth strategy, positioning Singapore as regional hub to expand across Asian markets. The Chelsea Clinic flagship brand relocated to Ngee Ann City.

Scale indicators10 records

Recent moves10 records

Expansion highlights7 records

Broad incumbents

• AbbVie (Allergan Aesthetics): Global pharmaceutical company whose Allergan Aesthetics division supplies Botox, CoolSculpting and the Juvederm franchise — the supply-side backbone of many aesthetic clinics. Comparable to SBC as a critical player in the aesthetic medicine value chain, although positioned as a product supplier rather than a clinic operator.
• IHH Healthcare: Asia-listed (KLSE, SGX) hospital operator with presence in Malaysia, Singapore, Turkey, India and Greater China. Comparable to SBC as a multi-country Asian healthcare services provider with expansion ambitions, although focused on tertiary hospitals rather than aesthetic clinics.
• Kao Corporation: Japan-listed consumer-products and beauty conglomerate with growing aesthetic and skincare operations. Comparable to SBC as a Japanese consumer-beauty platform, but at much larger scale with mostly non-medical product offerings.
• Galderma: Public dermatology-focused aesthetics company (SIX-listed spin-off from Nestlé) selling fillers, botulinum toxin and skincare. Comparable to SBC as a global aesthetics/dermatology incumbent that the SBC network partners with and competes against for patient share.
• Shiseido: Japanese personal-care and prestige-beauty conglomerate with a large aesthetic dermatology and clinic footprint across Asia. Comparable to SBC as a Japan-anchored incumbent in aesthetic medicine and dermatology, although Shiseido's clinic operations are part of a much broader cosmetics portfolio.

Direct peers

• Ideal Image: One of the largest U.S. medspa chains offering laser hair removal, injectables and body-contouring across ~150 locations. Closest direct comp to SBC's Shonan Beauty Clinic franchise model in terms of service mix (laser hair removal, anti-aging) and consumer positioning, validating the franchise-clinic concept in a more developed market.
• LaserAway: U.S. medspa franchise with ~180 locations concentrated in the Western U.S., offering laser hair removal, skin treatments and injectables. Comparable to SBC in franchise-style geographic expansion, aesthetic service mix and consumer target demographic.
• Beauty Health Company (Hydrafacial): Public company (SKIN) commercialising the Hydrafacial system and treatment network across providers and medspas globally. Comparable to SBC's aesthetic-treatment platform model with recurring service revenue and a focus on the high-end consumer aesthetic experience.

Others

• InMode: NASDAQ-listed developer of aesthetic medical devices (body contouring, skin treatment, hair removal lasers). Comparable to SBC as an enabling infrastructure provider whose devices are used inside Shonan Beauty Clinic and NEO Skin Clinic locations.

Emerging players

• Hims & Hers Health: NYSE-listed direct-to-consumer wellness and aesthetics platform with a subscription/recurring-revenue model. Comparable to SBC in consumer-facing aesthetics and recurring revenue characteristics, although Hims & Hers is virtual-first rather than clinic-based.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights6 records

Customer concentration

• Instagraminstagram.com/aesthetic.clinic.japan
• LinkedInlinkedin.com/company/sbc-medical-group-holdings-inc

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries4 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SBC Medical Group